Detalles de la búsqueda
1.
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers.
Mol Cell Proteomics
; 22(7): 100580, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211046
2.
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Br J Cancer
; 130(4): 613-619, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38182687
3.
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.
Br J Clin Pharmacol
; 90(5): 1333-1343, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403473
4.
Outcomes and toxicity of concurrent CDK4/6 inhibitor and locoregional radiotherapy for patients with de novo metastatic breast cancer.
Int J Cancer
; 153(7): 1386-1396, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37381597
5.
CANTO skin: Evaluation of skin toxicity risk factors in patients treated for breast cancer.
Int J Cancer
; 153(10): 1797-1808, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572223
6.
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
Cancer
; 129(7): 1085-1095, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642837
7.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat
; 199(2): 371-379, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988749
8.
TROP2, androgen receptor, and PD-L1 status in histological subtypes of high-grade metaplastic breast carcinomas.
Histopathology
; 82(5): 664-671, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36527253
9.
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
Eur J Nucl Med Mol Imaging
; 50(13): 4024-4035, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606858
10.
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer.
Int J Cancer
; 151(7): 1098-1108, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489021
11.
Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
Cancer
; 128(19): 3552-3563, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35913436
12.
Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study.
Br J Cancer
; 127(5): 886-891, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35715631
13.
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients.
Breast Cancer Res
; 23(1): 31, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676547
14.
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
Br J Cancer
; 124(7): 1207-1213, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33473163
15.
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue.
Breast Cancer Res Treat
; 190(3): 517-529, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559354
16.
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Breast Cancer Res Treat
; 189(3): 689-699, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34414532
17.
Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub-study of the French CANTO cohort.
Psychooncology
; 30(4): 463-470, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33052613
18.
Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapy.
Breast Cancer Res
; 22(1): 98, 2020 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32928264
19.
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.
Breast Cancer Res
; 22(1): 55, 2020 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32460829
20.
Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature.
Br J Cancer
; 123(6): 905-908, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32595213